Integration target site selection by a resurrected human endogenous retrovirus
about
Paleovirology--modern consequences of ancient virusesThe biased nucleotide composition of the HIV genome: a constant factor in a highly variable virusMouse endogenous retroviruses can trigger premature transcriptional termination at a distanceHuman endogenous retroviruses and the nervous systemAltering murine leukemia virus integration through disruption of the integrase and BET protein family interactionA new class of multimerization selective inhibitors of HIV-1 integraseIntegration and Fixation Preferences of Human and Mouse Endogenous Retroviruses Uncovered with Functional Data AnalysisEpigenetic Control of Human Endogenous Retrovirus Expression: Focus on Regulation of Long-Terminal Repeats (LTRs)Deciphering the code for retroviral integration target site selectionHigh-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion.HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2Regulatory activities of transposable elements: from conflicts to benefits.Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trialDistributions of transposable elements reveal hazardous zones in mammalian introns.Genomic flexibility of human endogenous retrovirus type KGene properties and chromatin state influence the accumulation of transposable elements in genesThe BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.HERV-K(HML-2), a seemingly silent subtenant - but still waters run deep.A prospective on drug abuse-associated epigenetics and HIV-1 replication.Human-specific HERV-K insertion causes genomic variations in the human genome.The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clonesAssessing the potential for AAV vector genotoxicity in a murine model.Global gene disruption in human cells to assign genes to phenotypes by deep sequencing.A method to sequence and quantify DNA integration for monitoring outcome in gene therapy.Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemia.Chromatin landscapes of retroviral and transposon integration profilesDecade-long safety and function of retroviral-modified chimeric antigen receptor T cells.Retroviral integration site selection.Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo deliveryKey determinants of target DNA recognition by retroviral intasomes.Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related SequencesGenome-Wide Screening of Genes Required for Glycosylphosphatidylinositol Biosynthesis.HIV DNA integration.Gene activity in primary T cells infected with HIV89.6: intron retention and induction of genomic repeats.INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular GenomesEvaluating risks of insertional mutagenesis by DNA transposons in gene therapy.Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV GagAnalysis of phage Mu DNA transposition by whole-genome Escherichia coli tiling arrays reveals a complex relationship to distribution of target selection protein B, transcription and chromosome architectural elements.BET proteins promote efficient murine leukemia virus integration at transcription start sites.Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.
P2860
Q21092724-001D12EB-82D8-480C-A408-D41EBFB7367BQ24498670-CBBB6DEC-9458-4E09-9778-0875B644284EQ24632767-7184167D-6223-45AA-9260-9A7812BC580FQ27012467-CF6DEAC5-3B4B-46A8-951B-CBAC421327C6Q27682160-62E53655-0DFF-44EC-A694-A3B238623DE2Q27683994-A79784C7-8798-4D13-B53D-8501AF6D534EQ30000090-2BEADED2-4E52-40F7-BDEA-8C5B3FE94C06Q30234309-CF79DA5C-C4A2-43FE-9BA2-2EB7CA99482BQ33760990-E2F0320E-90D5-44A6-9A8D-1402984FA183Q33784684-99D10185-821F-489C-A5D6-6E7190F463ECQ33851502-E87B77AF-056B-4CE4-A489-0C6EE4245912Q33874818-DEAF36BC-1E23-4397-909C-B486CEBEB0CFQ33896692-2ABF9896-07EF-4131-A35A-7C2906D2EB2BQ33900826-BEBD2A8D-5618-44E6-BE26-079E4DECE536Q34059466-13AC6886-2111-493B-B31E-AAF80B819B45Q34137519-2BC3F1A4-2451-4B11-B59B-5620E059DCF2Q34342339-20BE2CCF-32AD-404C-AE5E-32E58BBD40C8Q34511101-EDFF57AF-C5BD-4BCC-900F-447D5D9EB518Q34612737-4CB01548-703F-4B08-A2CE-E1746EAE8F62Q34673541-3DA7B4BE-37AB-4393-B0C5-9E543FAAFB67Q34707243-CC00329D-722B-4F32-AD63-78E58DACD3EAQ34754355-4CCB48CF-2318-45A7-8CFE-3435897507BFQ35036768-EF951E86-C1C0-4AC5-AF41-EBE0E19B0D04Q35041012-F9F96873-8743-43D2-A4C4-D195C2E69DF3Q35086103-474D5407-B6BA-49BC-9FF8-36ECF3BA36F2Q35144895-7B4CE96A-3788-4A30-8F3C-45A44DCDD1DFQ35202343-A75B0435-2E01-44A1-BE49-F98FCBF083E8Q35260206-17062844-DF5F-4457-B78E-53BBB958C7B9Q35399152-8441D142-02F2-40CD-B855-6E04FF851E03Q35577172-A4D2374B-7FD4-4B29-92B3-7E77544BCBF3Q35758600-0347F5F4-954B-491F-A98B-F11B82016F9CQ35780370-A5A23C76-57A1-41B4-8EF0-CAFB81410CAFQ36065855-760B6D2B-C5E1-4786-AFC1-A71B4C8773F2Q36071452-6EBD1A8C-0F0B-4580-8840-7D1BD6932561Q36323403-96B8C7DF-A204-40C8-B08E-E80D189C8E0DQ36698269-FDD0A7AF-2351-4470-A5FF-A3FE15B0CCF5Q36915626-D3504FD3-BC03-405E-8435-FC2D508224B1Q37017245-A35B24CD-134B-4A19-9D91-6E0ABD901BDCQ37031911-C372F9EB-71C6-4E29-A2EF-61667452E11EQ37734367-FB8E2B72-B701-41EF-9A83-84F6783BE250
P2860
Integration target site selection by a resurrected human endogenous retrovirus
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Integration target site selection by a resurrected human endogenous retrovirus
@en
Integration target site selection by a resurrected human endogenous retrovirus.
@nl
type
label
Integration target site selection by a resurrected human endogenous retrovirus
@en
Integration target site selection by a resurrected human endogenous retrovirus.
@nl
prefLabel
Integration target site selection by a resurrected human endogenous retrovirus
@en
Integration target site selection by a resurrected human endogenous retrovirus.
@nl
P2093
P2860
P356
P1433
P1476
Integration target site selection by a resurrected human endogenous retrovirus
@en
P2093
Charles C Berry
Keshet Ronen
Nirav Malani
Paul D Bieniasz
Troy Brady
Young Nam Lee
P2860
P304
P356
10.1101/GAD.1762309
P577
2009-03-01T00:00:00Z